Although CFM-4 has been demonstrated to activate pro-apoptotic p38SAPK in breast cancer cells [16], our current studies indicate that in addition to p38SAPK, CFM-4 also activates JNK in MB cells (see figures 4 and 6). Here, MAPK8 is linked to breast cancer.